Training activity information
Details
Perform and interpret assays for the detection of drugs of abuse in urine for the following:
- Heroin
- Morphine
- Codeine
- Methadone
- Cannabis
- Cocaine benzodiazepines (including diazepam),
- Amphetamine
- MDMA
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Local and national training guidelines, standards and pathways
- Method selection, including pre-analytical issues, assay advantages and limitations, quality parameters, and interferences
- Equipment calibration and maintenance
- Quality control; EQA and IQC
- National and international guidelines
- Analyte “cut offs”
- Role of the duty biochemist
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Analyse drugs, vitamins and trace elements in various biological matrices via quantitative and qualitative assays using automated and manual methodologies. |
| # 2 |
Outcome
Apply the appropriate investigative strategy to clinical situations which may involve drugs or poisons, advising clinical teams on the appropriate course of action. |
| # 3 |
Outcome
Appraise the methods in routine use for ‘drugs of abuse’ screening and advise on the interpretation of common analytes. |